No Data
No Data
Dawnrays Pharmaceutical Grants 16 Million Share Options to CEO, Employees
Dawnrays Pharma (02348.HK) granted 16 million share options.
On October 3, Gelonhui reported that dawnrays pharma (02348.HK) announced on October 2, 2024, that the company granted a total of 16 million share options to several eligible employees in accordance with the 2023 stock option plan, but only after the acceptances of the grantee can it be realized.
There Are Some Reasons To Suggest That Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Are A Poor Reflection Of Profitability
DAWNRAYS PHARMA: 2024 INTERIM REPORT
Dawnrays Pharma (02348): Wu Weixian resigns as the company's President.
Dawnrays Pharma (02348) announced that Mr. Wu Weixian (Mr. Wu) has resigned due to the need to focus on other personal affairs.
Express News | Dawnrays Pharmaceutical (Holdings) Ltd - Wu Weixian Tendered His Resignation as CEO
No Data
No Data